Literature DB >> 7637000

Herpes simplex virus immediate-early protein ICP22 is required for viral modification of host RNA polymerase II and establishment of the normal viral transcription program.

S A Rice1, M C Long, V Lam, P A Schaffer, C A Spencer.   

Abstract

Infection of cells with herpes simplex virus type 1 (HSV-1) results in a rapid alteration of phosphorylation on the large subunit of cellular RNA polymerase II (RNAP II), most likely on its C-terminal domain (S. A. Rice, M. C. Long, V. Lam, C. A. Spencer, J. Virol. 68:988-1001, 1994). This phosphorylation modification generates a novel form of the large subunit which we have designed IIi. In this study, we examine roles that HSV-1 gene products play in this process. An HSV-1 mutant defective in the immediate-early transcriptional activator protein ICP4 is able to efficiently induce IIi. Viruses having mutations in the genes for the ICP0, ICP6, or ICP27 proteins are also competent for IIi formation. In contrast, 22/n199, an HSV-1 mutant which contains a nonsense mutation in the gene encoding the immediate-early protein ICP22, is significantly deficient in IIi induction. This effect is seen in Vero cells, where 22/n199 grows relatively efficiently, and in human embryonic lung (HEL) cells, where 22/n199 growth in more restricted. RNAP II is recruited into viral replication compartments in 22/n199-infected cells, indicating that altered phosphorylation of RNAP II is not a prerequisite for nuclear relocalization of RNAP II. In addition, we show by nuclear run-on transcription analysis that viral gene transcription is deficient in HEL cells infected with 22/n199. Viral late gene transcription does not occur efficiently, and antisense transcription throughout the genome is diminished compared with that of the wild-type HSV-1 infection. These transcriptional effects cannot be explained by differences in viral DNA replication, since 22/n199 replicates its DNA efficiently in HEL cells. Our results demonstrated that ICP22 is necessary for virus-induced aberrant phosphorylation of RNAP II and for normal patterns of viral gene transcription in certain cell lines.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7637000      PMCID: PMC189408     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  63 in total

1.  Virulence of and establishment of latency by genetically engineered deletion mutants of herpes simplex virus 1.

Authors:  B Meignier; R Longnecker; P Mavromara-Nazos; A E Sears; B Roizman
Journal:  Virology       Date:  1988-01       Impact factor: 3.616

2.  Regulation of cellular genes transduced by herpes simplex virus.

Authors:  B Panning; J R Smiley
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

3.  Mutations in RNA polymerase II enhance or suppress mutations in GAL4.

Authors:  L A Allison; C J Ingles
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

4.  Induction and repression of cellular gene transcription during herpes simplex virus infection are mediated by different viral immediate-early gene products.

Authors:  L M Kemp; D S Latchman
Journal:  Eur J Biochem       Date:  1988-06-01

5.  The kinetics of expression of individual herpes simplex virus type 1 transcripts.

Authors:  Y F Zhang; E K Wagner
Journal:  Virus Genes       Date:  1987-11       Impact factor: 2.332

6.  The MO15 cell cycle kinase is associated with the TFIIH transcription-DNA repair factor.

Authors:  R Roy; J P Adamczewski; T Seroz; W Vermeulen; J P Tassan; L Schaeffer; E A Nigg; J H Hoeijmakers; J M Egly
Journal:  Cell       Date:  1994-12-16       Impact factor: 41.582

7.  Factor(s) present in herpes simplex virus type 1-infected cells can compensate for the loss of the large subunit of the viral ribonucleotide reductase: characterization of an ICP6 deletion mutant.

Authors:  D J Goldstein; S K Weller
Journal:  Virology       Date:  1988-09       Impact factor: 3.616

8.  The regions of the herpes simplex virus type 1 immediate early protein Vmw175 required for site specific DNA binding closely correspond to those involved in transcriptional regulation.

Authors:  T Paterson; R D Everett
Journal:  Nucleic Acids Res       Date:  1988-12-09       Impact factor: 16.971

9.  Partial purification and characterization of two distinct protein kinases that differentially phosphorylate the carboxyl-terminal domain of RNA polymerase subunit IIa.

Authors:  J M Payne; M E Dahmus
Journal:  J Biol Chem       Date:  1993-01-05       Impact factor: 5.157

10.  A herpes simplex virus type 1 ICP22 deletion mutant is altered for virulence and latency in vivo.

Authors:  K L Poffenberger; A D Idowu; E B Fraser-Smith; P E Raichlen; R C Herman
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

View more
  84 in total

1.  Multiple immediate-early gene-deficient herpes simplex virus vectors allowing efficient gene delivery to neurons in culture and widespread gene delivery to the central nervous system in vivo.

Authors:  C E Lilley; F Groutsi; Z Han; J A Palmer; P N Anderson; D S Latchman; R S Coffin
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

2.  Perturbation of cell cycle progression and cellular gene expression as a function of herpes simplex virus ICP0.

Authors:  W E Hobbs; N A DeLuca
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

3.  Functional anatomy of herpes simplex virus 1 overlapping genes encoding infected-cell protein 22 and US1.5 protein.

Authors:  W O Ogle; B Roizman
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

4.  RNA polymerase II holoenzyme modifications accompany transcription reprogramming in herpes simplex virus type 1-infected cells.

Authors:  H L Jenkins; C A Spencer
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

Review 5.  HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part I. HSV-1 structure, replication and pathogenesis.

Authors:  A Jacobs; X O Breakefield; C Fraefel
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

6.  Sequence variation in the herpes simplex virus U(S)1 ocular virulence determinant.

Authors:  Aaron W Kolb; Timothy R Schmidt; David W Dyer; Curtis R Brandt
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-06-28       Impact factor: 4.799

Review 7.  Herpes simplex virus virion host shutoff protein: immune evasion mediated by a viral RNase?

Authors:  James R Smiley
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

8.  Immediate-early expression of the herpes simplex virus type 1 ICP27 transcript is not critical for efficient replication in vitro or in vivo.

Authors:  Aixu Sun; G V Devi-Rao; M K Rice; L W Gary; D C Bloom; R M Sandri-Goldin; P Ghazal; E K Wagner
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

9.  A truncation mutation of the neurovirulence ICP22 protein produced by a recombinant HSV-1 generated by bacterial artificial chromosome technology targets infected cell nuclei.

Authors:  Robert N Bowles; John A Blaho
Journal:  J Neurovirol       Date:  2011-12-03       Impact factor: 2.643

10.  Herpes simplex virus type 1 infection leads to loss of serine-2 phosphorylation on the carboxyl-terminal domain of RNA polymerase II.

Authors:  Kathryn A Fraser; Stephen A Rice
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.